All articles by Abhishek Singh

HuTrial – human surrogates for clinical trials becomes a reality

In early June, Crown Bioscience unveiled its new human surrogate trial platform, HuTrial, which functions as a low-cost substitute for a phase-II trial. Through conducting a HuTrial, researchers could be able to predict the efficacy of a prospective candidate early in the drug development process, helping to reduce the failure rate at the later stages of clinical trials. Abby Miller spoke to Jean-Pierre Wery, president of Crown Bioscience, to find out more.